CRP and polycystic ovary syndrome: This study demonstrates that a composite assessment of first-trimester biochemical markers - CRP, uric acid, and PPBS - alongside key clinical risk factors such as PCOS and family history of diabetes, provides robust predictive accuracy for GDM.